|
CA2273852C
(en)
|
1996-12-06 |
2009-09-29 |
Amgen Inc. |
Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
|
|
US6660843B1
(en)
*
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
US7488590B2
(en)
|
1998-10-23 |
2009-02-10 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
ATE348163T1
(de)
|
1998-10-23 |
2007-01-15 |
Amgen Inc |
Thrombopoietin substitute
|
|
AT406054B
(de)
*
|
1998-11-04 |
2000-02-25 |
Andreas Bernkop-Schnuerch |
Verfahren zur verbesserung der mucoadhäsion von polymeren sowie deren herstellung und verwendung
|
|
AU5428300A
(en)
*
|
1999-06-21 |
2001-01-09 |
Santen Pharmaceutical Co. Ltd. |
Remedies for arthrosis deformans
|
|
CN1402642A
(zh)
*
|
1999-07-21 |
2003-03-12 |
奥默罗斯公司 |
用于抑制疼痛,炎症和软骨退化的溶液及方法
|
|
US6808902B1
(en)
|
1999-11-12 |
2004-10-26 |
Amgen Inc. |
Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
|
|
EP1278778A2
(en)
*
|
2000-05-03 |
2003-01-29 |
Amgen Inc., |
Modified peptides, comprising an fc domain, as therapeutic agents
|
|
US7324635B2
(en)
|
2000-05-04 |
2008-01-29 |
Telemaze Llc |
Branch calling and caller ID based call routing telephone features
|
|
EP1282435A2
(en)
*
|
2000-05-12 |
2003-02-12 |
Immunex Corporation |
Interleukin-1 inhibitors in the treatment of diseases
|
|
DE60139944D1
(de)
|
2000-10-12 |
2009-10-29 |
Genentech Inc |
Niederviskose konzentrierte proteinformulierungen
|
|
US8703126B2
(en)
|
2000-10-12 |
2014-04-22 |
Genentech, Inc. |
Reduced-viscosity concentrated protein formulations
|
|
US7087224B2
(en)
|
2000-10-31 |
2006-08-08 |
Amgen Inc. |
Method of treating anemia by administering IL-1ra
|
|
TR201809678T4
(tr)
|
2001-06-26 |
2018-07-23 |
Amgen Fremont Inc |
Opgl ye karşi antikorlar.
|
|
US6818613B2
(en)
|
2001-11-07 |
2004-11-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Aqueous sustained-release formulations of proteins
|
|
WO2003061626A1
(en)
*
|
2002-01-18 |
2003-07-31 |
Control Delivery Systems, Inc. |
Polymeric gel system for the controlled delivery of codrugs
|
|
MXPA04011470A
(es)
|
2002-05-21 |
2005-02-14 |
Amgen Inc |
Compuestos heterociclicos sustituidos y metodos de uso.
|
|
MXPA05002514A
(es)
|
2002-09-06 |
2005-05-27 |
Amgen Inc |
Anticuerpo monoclonal anti-il-1r1 humano terapeutico.
|
|
US7553827B2
(en)
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
|
US8273347B2
(en)
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
|
US7344716B2
(en)
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
|
US7429378B2
(en)
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
|
US8361467B2
(en)
*
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
|
US8895540B2
(en)
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
|
PL1729810T3
(pl)
*
|
2004-04-02 |
2019-02-28 |
Swedish Orphan Biovitrum Ab (Publ) |
Sposoby agregacji IL-1ra
|
|
CA2580796C
(en)
|
2004-09-24 |
2013-03-26 |
Amgen Inc. |
Modified fc molecules having peptides inserted in internal loop regions
|
|
CN103860582A
(zh)
*
|
2004-12-30 |
2014-06-18 |
建新公司 |
用于关节内粘弹性补充的方案
|
|
EP3725299A1
(en)
*
|
2005-06-24 |
2020-10-21 |
Duke University |
A direct drug delivery system based on thermally responsive biopolymers
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
AR056806A1
(es)
|
2005-11-14 |
2007-10-24 |
Amgen Inc |
Moleculas quimericas de anticuerpo rankl- pth/ pthrp
|
|
US7767206B2
(en)
|
2006-10-02 |
2010-08-03 |
Amgen Inc. |
Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
|
|
GB0708376D0
(en)
|
2007-05-01 |
2007-06-06 |
Alligator Bioscience Ab |
Novel polypeptides and uses thereof
|
|
US8323635B2
(en)
|
2007-11-14 |
2012-12-04 |
General Regeneratives, Ltd. |
Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
|
|
US8986696B2
(en)
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
|
WO2009108890A1
(en)
|
2008-02-27 |
2009-09-03 |
Biomet Biologics, Llc |
Methods and compositions for delivering interleukin-1 receptor antagonist
|
|
KR200451958Y1
(ko)
*
|
2008-10-09 |
2011-01-21 |
(주)에이치시티 |
모바일기기용 카드형 안테나장치
|
|
PE20120359A1
(es)
|
2009-03-06 |
2012-04-13 |
Genentech Inc |
Formulacion con anticuerpo
|
|
US20110052561A1
(en)
*
|
2009-08-27 |
2011-03-03 |
Biomet Biologics,LLC |
Osteolysis treatment
|
|
TW201117824A
(en)
|
2009-10-12 |
2011-06-01 |
Amgen Inc |
Use of IL-17 receptor a antigen binding proteins
|
|
CN101690801B
(zh)
|
2009-10-26 |
2012-08-01 |
上海交通大学 |
白细胞介素-1受体拮抗剂的用途及其药物组合物
|
|
DE202009017772U1
(de)
|
2009-12-10 |
2011-04-21 |
Orthogen Ag |
Kombinationspräparate mit Cytokin-Antagonist und Corticosteroid
|
|
RU2563830C2
(ru)
*
|
2011-02-08 |
2015-09-20 |
Эббви Инк. |
Лечение остеоартрита и боли
|
|
BR112013020195B1
(pt)
|
2011-02-11 |
2020-01-07 |
Swedish Orphan Biovitrum Ab (Publ) |
Composição farmacêutica livre de citrato compreendendo anakinra e uso de anakinra
|
|
US20140234330A1
(en)
|
2011-07-22 |
2014-08-21 |
Amgen Inc. |
Il-17 receptor a is required for il-17c biology
|
|
WO2013030348A1
(en)
|
2011-09-02 |
2013-03-07 |
Novozymes Biopharma Dk A/S |
Oral formulations containing hyaluronic acid for sustained drug release
|
|
US10143725B2
(en)
|
2013-03-15 |
2018-12-04 |
Biomet Biologics, Llc |
Treatment of pain using protein solutions
|
|
US9895418B2
(en)
|
2013-03-15 |
2018-02-20 |
Biomet Biologics, Llc |
Treatment of peripheral vascular disease using protein solutions
|
|
US9878011B2
(en)
|
2013-03-15 |
2018-01-30 |
Biomet Biologics, Llc |
Treatment of inflammatory respiratory disease using biological solutions
|
|
US20140271589A1
(en)
|
2013-03-15 |
2014-09-18 |
Biomet Biologics, Llc |
Treatment of collagen defects using protein solutions
|
|
US9758806B2
(en)
|
2013-03-15 |
2017-09-12 |
Biomet Biologics, Llc |
Acellular compositions for treating inflammatory disorders
|
|
AU2014333953C1
(en)
*
|
2013-10-08 |
2020-06-25 |
Ascendis Pharma A/S |
Hydrogel-linked IL-1ra prodrug
|
|
WO2015191783A2
(en)
|
2014-06-10 |
2015-12-17 |
Abbvie Inc. |
Biomarkers for inflammatory disease and methods of using same
|
|
CZ309295B6
(cs)
*
|
2015-03-09 |
2022-08-10 |
Contipro A.S. |
Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
|
|
US10041044B2
(en)
|
2016-07-29 |
2018-08-07 |
Trustees Of Boston University |
Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development
|
|
JP7216006B2
(ja)
|
2017-03-22 |
2023-01-31 |
ジェネンテック， インコーポレイテッド |
ヒドロゲル架橋ヒアルロン酸プロドラッグ組成物及び方法
|
|
US11819536B2
(en)
|
2018-06-22 |
2023-11-21 |
The Trustees Of Columbia University In The City Of New York |
Sustained release compositions and methods for treatment of temporomandibular joint degeneration
|
|
EP3836954B1
(en)
|
2018-08-13 |
2025-05-07 |
Iltoo Pharma |
Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof
|
|
US12370240B2
(en)
|
2018-11-28 |
2025-07-29 |
Genascence Corporation |
Methods and compositions for treating osteoarthritis
|
|
WO2021026289A1
(en)
|
2019-08-08 |
2021-02-11 |
Avidence Therapeutics, Inc. |
Microsphere-Based Injectible Celecoxib Formulation
|
|
US20250283174A1
(en)
|
2022-05-16 |
2025-09-11 |
Institut National de la Santé et de la Recherche Médicale |
Methods for assessing the exhaustion of hematopoietic stem cells induced by chronic inflammation
|